Ureteral stenting is a high-volume procedure with a patient experience that has remained largely unchanged for decades. At CatheGenix, we believe there is a better way.
We advance stent surface technology through anti-encrustation hydrophilic coating, making ureteral stenting smoother for clinicians and better for patients.
Smoother handing. predictableperformance, and easier removal.
Improved comfort potential and reduced stent-related burden.
Surface engineering focused on real clinical.
We concentrate on where surface performance matters most - in ureteral stent design. Our focus allows us to deliver targeted solutions rather than broad-line generic products.
Clinical credibility requires rigorous validation. Every performance claim behind Endura™ is supported by bench testing, evaluation, and transparent documentation.
We build long-term relationships with distributors, clinicians, and hospital procurement teams - based on product quality, consistent supply and accessible support.
From our founding mission to global partnerships, we are committed to advancing ureteral stent innovation through surface engineering.
CatheGenix established with a focused mission in ureteral stent innovation.
Endura™ surface platform development and bench testing.
Endura™ Ureteral Stents launched in initial markets.
Building distribution partnerships across key global markets.
Providing focused solutions for urological stone management based on real clinical needs.
Offering product information, application guidance, and market-ready materials for effective communication.
Ensuring consistent quality through controlled processes, performance evaluation, and traceable documentation.
Delivering stable supply, responsive service, and continuous support for our cooperation partners.
Endura™ anti-encrustation hydrophilic ureteral stent platform designed for smoother placement, reliable drainage, and easier removal!
Product availability, indications, specifications, and regulatory status may vary by country or region.
Products are intended for use by qualified healthcare professionals.
Claims are subject to applicable approvals and supporting documentation in the relevant market.